GLP – 1 agonists   Role in addiction The development of a novel class of medications for treatment of type 2 diabetes and obesity has become a commercial success with manufacturers struggling to meet demand.  Ozempic, produced by Novo Nordisk is expected to reach a market size of 10.99 billion usd in 2024. The overall market is expected … Continue reading Jeff K – GLP – 1 Agonists